Cardiovascular Disease Prevention at a Crossroads:: Precision Medicine or Polypill?

. 2019 Dec 17;322(23):2281-2282.

doi: 10.1001/jama.2019.19026.

Michael J Joyner¹, Nigel Paneth^{2

3}

Affiliations

¹ Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
² Departments of Epidemiology and Biostatistics, Michigan State University, College of Human Medicine, East Lansing.
³ Departments of Pediatrics and Human Development, Michigan State University, College of Human Medicine, East Lansing.

Michael J Joyner et al. JAMA. 2019.

. 2019 Dec 17;322(23):2281-2282.

doi: 10.1001/jama.2019.19026.

Michael J Joyner¹, Nigel Paneth^{2

3}

¹ Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
² Departments of Epidemiology and Biostatistics, Michigan State University, College of Human Medicine, East Lansing.
³ Departments of Pediatrics and Human Development, Michigan State University, College of Human Medicine, East Lansing.

No abstract available

Cited by

Pharmacologic Prehabilitation-What About "the Polypill"?
Reitz KM, Seymour CW, Neal MD. Reitz KM, et al. JAMA Surg. 2020 Nov 1;155(11):1083. doi: 10.1001/jamasurg.2020.3013. JAMA Surg. 2020. PMID: 32805047 Free PMC article. No abstract available.
Polypill for Population-Level Primary Cardiovascular Prevention in Underserved Populations-A Social Epidemiology Counterargument.
Cainzos-Achirica M, Bilal U. Cainzos-Achirica M, et al. Am J Med. 2020 Oct;133(10):e541-e543. doi: 10.1016/j.amjmed.2020.04.017. Epub 2020 May 20. Am J Med. 2020. PMID: 32442515 Free PMC article. No abstract available.